PenderFund Capital Management Ltd.

Q3 2024 13F Holdings Report, Stock Holdings

Signature - Title
Gina Jones - CFO
Location
Vancouver, British Columbia, Canada
Holdings as of
30 Sep 2024
Value $
$64,947,386
Num holdings
137
Filing time
14 Nov 2024, 11:24:52 UTC
Form type
13F-HR
Description
All US holdings of this investor are reported in this report. Top holdings included ESPERION THERAPEUTICS INC NE, CARDLYTICS INC, EVENTBRITE INC, ACCELERATE DIAGNOSTICS INC, and AQU.
Previous filing
Q2 2024 - 14 Aug 2024
Next filing
Q4 2024 - 14 Feb 2025
Our algorithm has found invalid data in this filing
Sym Weight Trade Impact Company Class Share Change Activity Value Change $ Value $ * Price $ Shares Principal
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.

Person Signing this Report on Behalf of Reporting Manager:

Name Title City, State Date
Gina Jones CFO Vancouver, British Columbia, Canada 14 Nov 2024